Eric Lefkofsky is looking to break down barriers in cancer treatment research with his new biotechnology company Tempus.
Eric Lefkofsky is no stranger to cancer research and community care. Lefkofsky’s wife, Liz, lost her sister to cancer as a young girl. The couple has donated thousands to cancer research over the years as a result. Lefkofsky has also helped fund for poor students in the Greater Chicago Area for years. He has provided the funds for scholarship programs, after-school activities, and dozens of arts programs.
Lefkofsky also has years of experience with business. Starting off as a carpet salesmen, he learned through both failure and success. Lefkofsky became an expert on creating, buying, and selling companies for a profit. This led to him founding the popular website Groupon in 2008.
Lefkofsky’s philosophy of giving back to his community took a turn into cancer research after his wife was diagnosed with cancer. During her treatment, Lefkofsky noticed a trend with oncologists that he found troubling: they did not communicate with each other. Even more troubling, he found this was not due to their own failings but the failings of the system they are forced to work within. To put the problem simply, doctors have no idea what treatments are working and why and more information click here.
If a doctor is trying to figure out whether their medication works, they need to know exactly what’s going on with their patient. Think about something as simple as a 6th grade science project. If a student is studying how much sunlight a plant needs to grow, they need to control all other variables. If one plant is being watered more, that could effect its health and skew the data and Eric’s lacrosse camp.
This idea applies to real life also. When looking at clinical trials, a doctor needs to know whether those patients were on other medication, if they had other sicknesses, and on and on. To access this vital information, they need to get through miles of red tape, which could take months. Lefkofsky aims to break these barriers down so oncologists can communicate freely and learn more about Eric.
More visit: www.forbes.com/profile/eric-lefkofsky